Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2898200011 | Metformin hydrochloride 500mg + Saxagliptin 5mg extended release tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2902283018 | Metformin hydrochloride 500mg + Saxagliptin 5mg extended release tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3761804014 | Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3761805010 | Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Is a | Metformin hydrochloride + saxagliptin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Is a | Combination oral hypoglycemic | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has active ingredient | Metformin hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has active ingredient | Saxagliptin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | Extended-release tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Is a | Product containing metformin in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | Prolonged-release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has basis of strength substance | Metformin hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has basis of strength substance | Saxagliptin | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has presentation strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has presentation strength numerator value | 5 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has precise active ingredient | Metformin hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has precise active ingredient | Saxagliptin hydrochloride | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Is a | Product containing only metformin and saxagliptin in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR